Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1970 May;6(5):733-9.

Anti-adrenal cellular hypersensitivity in Addison's disease. IV. In vivo and in vitro investigations on the mitochondrial fraction

Anti-adrenal cellular hypersensitivity in Addison's disease. IV. In vivo and in vitro investigations on the mitochondrial fraction

J Nerup et al. Clin Exp Immunol. 1970 May.

Abstract

Nine patients with idiopathic Addison's disease and three patients with diabetes mellitus and circulating anti-adrenal antibody but without Addison's disease were studied.

The organ-specific, anti-adrenal cellular hypersensitivity previously demonstrated by means of the leucocyte migration test in patients with idiopathic Addison's disease was found to be directed against the mitochondrial fraction of normal, human, foetal adrenocortical cells as well as of human, benign hyperplastic adrenal glands. The mitochondrial fraction of human, foetal liver cells did not cause inhibition of migration.

In lymphocyte cultures from the patients with idiopathic Addison's disease the adrenocortical, mitochondrial fraction did not induce blast transformation. The two in vitro reactions therefore probably express different kinds of reactivity.

The adrenocortical mitochondrial fraction was able to elicit intracutaneous reactions of delayed type in patients with a positive leucocyte migration test to the same antigen. This observation confirms, that inhibition of leucocyte migration in vitro indicates a state of anti-adrenal cellular hypersensitivity in patients with idiopathic Addison's disease.

PubMed Disclaimer

References

    1. J Immunol. 1966 Aug;97(2):239-47 - PubMed
    1. Acta Med Scand. 1967 Feb;181(2):247-56 - PubMed
    1. Acta Med Scand. 1968 Jul-Aug;184(1-2):135-9 - PubMed
    1. Lancet. 1969 Jun 14;1(7607):1212-3 - PubMed
    1. Clin Exp Immunol. 1969 Apr;4(4):355-63 - PubMed

LinkOut - more resources